venture capital, Andreessen Horowitz and Eli Lilly

Spurred by AI’s possibilities, Eli Lilly and Andreessen Horowitz partner on $500M venture fund
Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of the drug giant’s money.
Eli Lilly, Andreessen Horowitz link up on $500M biotech venture fund
Eli Lilly and venture capital firm Andreessen Horowitz (a16z) are joining forces to create a unique new fund dubbed the Biotech Ecosystem Venture Fund, backed by $500 million of Lilly’s capital.
Andreessen Horowitz Partners with Lilly to Launch First-of-Its-Kind Biotech Ecosystem Venture Fund
Bio + Health today announced a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health, in partnership with Eli Lilly and Company ("Lilly"). The Biotech Ecosystem Venture Fund ("Fund") seeks to drive transformative progress in healthcare by investing in therapeutic platforms and cutting-edge technology companies that can bring new medicines and disease treatments to improve patients’ lives.
Andreessen Horowitz, Eli Lilly to launch $500 million venture fund
Venture capital firm Andreessen Horowitz said on Friday it was working with Eli Lilly to launch a $500 million venture fund that will be fully funded by the U.S. drugmaker.
Lilly Partners With a16z on $500M VC Fund for Early-Stage Biotechs
The Biotech Ecosystem Venture Fund will combine the sourcing capabilities of venture capital firm Andreessen Horowitz (a16z) with Eli Lilly’s expertise in R&D—plus half a billion in capital from the Big Pharma.
STAT7h
Intellia cuts 27% of staff, in the latest wave of gene-editing layoffs
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Silicon Valley is licking its chops at the promise of AI 'agents.' These are the startups to watch.
The rise of agents, a new set of artificial intelligence tools that can work autonomously, offers a fertile ground for a ...
Andreessen Horowitz Wants to Shoehorn AI Into Everything in 2025. Whether You Want It or Not.
Waves of hype have been unleashed on the public since ChatGPT’s unveiling in 2022. And investors have no intention of slowing down.
Three A16Z Predictions For Crypto Spring And Why Only Two Are Right
Venture capitalists Andreessen Horowitz have released their predictions for “crypto”. I’ve picked three key areas where I ...
Modern Healthcare14h
Top digital health funding: Hippocratic AI gets $141M
Hippocratic AI, a company developing a generative artificial intelligence for healthcare providers, has closed a $141 million ...
Hippocratic AI raises $141M for creating patient-facing AI agents
Hippocratic AI, a startup building AI solutions that can handle non-diagnostic patient-facing tasks, secured a massive $141 ...